Survival in Cats with Naturally Occurring Chronic Kidney Disease (2000–2002)

Abstract

BACKGROUND: Duration of survival of cats with naturally occurring chronic kidney disease (CKD) is poorly characterized. HYPOTHESIS: Stage of kidney disease based on serum creatinine concentration (SCr) at the time of diagnosis and after correction of prerenal azotemia is strongly associated with duration of survival in cats. ANIMALS: Two hundred and eleven client-owned cats with naturally occurring CKD evaluated between April 2000 and January 2002. METHODS: Retrospective case review of 733 cats with SCr > 2.3 mg/dL. Examination of the medical records identified 211 cats that met all other inclusion and exclusion criteria for this study. Clinical characteristics, clinicopathologic data, and survival times were extracted from the medical record. Owners and referring veterinarians were contacted by phone to obtain follow-up if it was not documented in the record. Kaplan-Meier survival curves were performed to determine survival times for International Renal Interest Society (IRIS) stage both at diagnosis and at baseline (ie, after correction of prerenal azotemia). RESULTS: Median survival for cats in IRIS stage IIb at the time of diagnosis was 1,151 days (range 2-3,107), and was longer than survival in stage III (median 778, range 22-2,100) or stage IV (median 103, range 1-1,920) (P-value< .0001). P-value for effect of stage at diagnosis was < .0001. CONCLUSIONS AND CLINICAL IMPORTANCE: IRIS stage of CKD based on serum creatinine at the time of diagnosis is strongly predictive of survival in cats with naturally occurring CKD.